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Summary In a study of factors related to cervical carcinogenesis, a cohort of 1,107 cervical dysplasia along
with 1,077 controls matched for age and parity were followed up prospectively. During the follow up 75
dysplasia cases progressed to carcinoma in situ. The overall rate of progression of dysplasia to malignancy was
observed to be 15.7% at the end of 108 months of follow-up. The analysis of progression rates in relation to
various factors revealed significantly higher progression rates for initially higher grade of dysplastic lesions,
and early age at consummation of marriage (ACM). The other factors, such as religion, literacy status of the
patient, number of pregnancies, presence of cervical erosion, history of fetal loss and positivity to HSV-II
antibodies, did not reveal statistical significance. The case-control comparison for detection of HPV 16/18 by
in situ hybridisation revealed the presence of HPV 16/18 sequences in 67.3% of the dysplasia subjects
progressed to carcinoma in situ while 27.3% of precancerous cases regressed to normalcy. The difference was
found to be statistically significant (P<0.001).
The natural history of cervical cancer has been well estab-
lished (IARC, 1986). However, comparative information on
the subject is lacking from developing countries. WHO, in a
meeting held in 1986, recommended the generation of such
information from developing countries. Earlier we com-
municated information on the natural history of cervical
cancer of Indian women (Luthra et al., 1987). This com-
munication deals with the biological behaviour of
precancerous lesions and the effect of certain socio-
demographic and biological factors on the progression of
dysplasia to carcinoma in situ. Although several studies are
available from India, highlighting the risk factors for invasive
cervical cancer (Jussawala et al., 1971; Wahi et al., 1972;
Luthra et al., 1975), this study is unique in the sense that it
examines the effect of some factors on the progression of
dysplasia prospectively as compared to dysplasia that did not
progress to carcinoma in situ during the same period. Thus, it
highlights the risk modifying effect of these factors on dys-
plasia.
Materials and methods
Screening and cohortformation
Cervical smears were collected from squamo-columnar junc-
tion of cervix from 120,411 married women in the age group
of 20-60 years attending the gynaecological outpatient
department (OPDs) of the six major hospitals in the met-
ropolitan city of Delhi, India, during the period 1976-87.
Clinical history and a brief information on other pparameters
was obtained at this visit. The cytological examination of
women with adequate smears (n = 117,411) revealed that
30,397 (25.9%), 84,889 (72.3%), 1,910 (1.6%) and 215
(0.2%) were negative, inflammation, dysplasia and malignant
cases, respectively. Those revealing dysplasia, and who were
residents of Delhi for the past I year, were asked to undergo
a second pap smear test on the fifteenth day. Thus 1,107
women who revealed dysplasia at the initial visit as well as at
day 15 were registered in the cohort for long-term follow-up.
In case of discrepancy of the two cytosmears (i.e. initial and
15 days) the higher diagnosis was noted for registration of
the case. For instance, if the first smear was moderate dys-
plasia and the second smear showed mild dysplasia, the case
was registered as a case of moderate dysplasia. Women
revealing normal or inflammatory smears without any past
history ofcervical abnormalities or treatment for such abnor-
malities were randomly selected as controls (n = 1,077) after
matching for age and parity of dysplasia cases. The project
protocol of the study and the procedure for recruitment of
cases and control for long-term follow-up was approved by
the ethical committee.
Since no organised cytology screening programme exists in
India, none of the women in the present study had under-
gone any Pap test earlier.
Dysplasia subjects and their husbands were contacted by a
team of trained medical social workers and gynaecologists to
educate them about the objectives of the study and to elicit
their co-operation. All the subjects agreed to participate in
the study.
Base line information andfollow-up
The details of subject selection and investigational procedure
have been described earlier (Luthra et al., 1987). In brief,
information on epidemiological parameters, such as demo-
graphic particulars, literacy status of both partners, occupa-
tion status and reproductive history including adoption of
family planning practices, were also recorded. Moderate and
severe dysplasia,cases were followed up at 3-monthly inter-
vals, mild dysplasia and control subjects were followed up at
6-monthly and yearly intervals respectively. At each follow-
up visit, detailed clinical and colposcopic examination was
carried out in addition to Pap smear collection. The end-
point of the study was carcinoma in situ. Whenever malig-
nancy (CIS) was detected in cytological examination or a
higher grade lesion was suspected through colposcopic
examination, biopsy was performed to confirm the diagnosis.
The subjects registered during 1976 had completed 132
months of follow-up while those registered in December 1985
had completed 15 months of follow-up by March 1987. The
diagnosis of cervical dysplasia was made according to the
criteria proposed by the World Health Organization (Riotten
et al., 1973). At the time of enrolment, a thorough clinical
and colposcopic assessment was made and 5 ml of intra-
venous blood was drawn for detection of antibody to herpes
simplex virus (HSV) type I and 1I, through an indirect
haemagglutination test (IHA).
Laboratory procedures
HSV For standardising the technique, recurrent herpes
genitals, recurrent herpes of lips and face and active herpes
simplex (HSV) infections were assayed for HSV-I and HSV-
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II antibodies by IHA and IHAI. Tests of the three parameters
IHA, IHAI and II/I index revealed that only the II/I index at
a threshold value of 85 could differentiate between HSV-I and
HSV-II infection (Seth et al., 1978; Sharma et al., 1985).
The index was calculated as:
antibody of titre to HSV II (log 10)
II/I index = antibody of titre to HSV I (log 10)
An index value of <85 indicated HSV I antibody activity
whereas a value of >85 was considered to indicate HSV II
antibody activity.
HPV For in situ hybridisation, paraffin sections obtained
on processed slides were hybridised with 3H-thymidine
(Amersham, UK) labelled HPV 16 and 18 vector free inserts
(viral plasmids were kindly provided by Prof. Herald zur
Hausen, German Cancer Research Centre, Heidelberg, F.R.
Germany). After hybridisation and washing under stringent
conditions (Tm = - 20°C) the slides were coated in NTB2
autoradiographic emulsion (Kodak, USA) and, after
exposure at 4°C for 4-6 weeks, the slides were developed and
stained. Observation of slides was made using a Zeiss
photomicroscope under oil immersion. The investigations of
human papilloma virus were done on limited samples consist-
ing of dysplasia cases progressed to malignancy (n = 63) and
women with dysplastic lesions that regressed to normalcy
(n = 44). For the progressing cases the biopsy was taken at
the end-point (CIS) while for the non-progressing cases
(dysplasia that regressed to normalcy) the biopsy was taken
at the conclusion of the study, i.e. in 1987, after obtaining
consent from the patients. Non-progressing cases were ran-
domly selected and were group matched for age and initial
grade of dysplasia. Ideally, the biopsy from the non-
progressing cases should have been taken after matching for
the follow-up interval but that would have disturbed the
natural history of the disease.
Statistical analysis
The number of women exposed to the risk at different
follow-up periods was calculated employing the life table
technique after allowing for known causes of attrition, i.e.
hysterectomy, progression to malignancy, death and perma-
nent move from the city. The incidence of malignancy per
100 women years of follow-up was estimated. The estimate of
cumulative rates of progression from dysplasia to malignancy
was calculated using the actuarial survival method (Kaplan &
Meier, 1958). The differences in the progression rates between
the two groups were tested employing log rank test (Mathews
& Farewell, 1985).
The Cox proportional hazards regression model (Cox,
1972) was employed to quantify the relationship between
progression to malignancy (considering the period of follow-
up) and a set of risk factors (except HPV). Initially through
the univariate analysis a set of regression coefficients/relative
risks was estimated which related the effect of each risk
factor for progression to malignancy. Further, in order to
identify independent risk factors, multivariate stepwise
methodology was employed. All the computations were car-
ried out using an IBM PC with the BMDP package.
Since the investigations for detection of HPV was done on
a case-control design, odds ratios were estimated.
Results
Age andparity ofdysplasia cases
Of the 1,107 dysplasia cases registered for follow-up, 710
(64.1%) were mild, 305 (27.6%) moderate and 92 (8.3%)
severe dysplasia. The mean ages ofmild, moderate and severe
dysplasia cases at the time of registration were 34.0, 34.0 and
35.7 years respectively and the mean parities were 3.3, 3.5
and 3.9 respectively.
Follow-up rates
The rates offollow-up ranged from 74.1 to 100% at different
follow-up periods of 12-132 months (Table I). The rate of
follow-up between different grades of dysplasia as well as
control group was observed to be similar. During the course
of follow-up, 103 (9.3%) dysplasia cases and 30 (2.8%) con-
trol women had undergone hysterectomy for reasons such as
persistent unhealthy cervix, fibroid uterus and dysfunctional
uterine bleeding. Of 1,107 dysplasia cases, 316 (28.5%)
moved out of Delhi permanently and 11 women (1.0%) died
due to reasons other than cancer at different follow-up
periods.
Progression to malignancy within 3 months
Of 1,107 dysplasia cases followed up, 64 (5.8%) revealed
malignancy within 3 months of registration. Since this very
short conversion interval may be due to false negative entry
smears, only those cases of dysplasia that progressed to
carcinoma in situ beyond 3 months of follow-up were
included for progression to malignancy. Of the 64 women
who revealed malignancy within 3 months, the repeat cervical
smears revealed clear malignancy in 36 cases which were later
confirmed by histology. In the other 28 women, there was a
clinical suspicion of a higher grade of lesion. A biopsy taken
to rule out such a possibility revealed the malignancy.
Incidence rate ofmalignancy beyond 3 months offollow-up
During the study period 75 cases of dysplasia and four
controls progressed to malignancy (through various grades of
dysplasia) at different follow-up periods (as confirmed histo-
logically).
Incidence rate
The incidence rate of cancer per 100 women years of follow-
up was 17 times more for all dysplasias (2.50) than for the
corresponding controls (0.15). There was a marked variation
in progression to malignancy among initially mild (0.73),
moderate (5.08) and severe (15.6) dysplasia cases.
Cumulative progression rates
The progression rates from dysplasia to malignancy at
different follow-up periods for women with initially mild,
moderate, severe and all dysplasias are presented in Table II.
The progression rate to malignancy among all dysplasia
cases at the end of 108 months was observed to be 15.7%.
Although the follow-up was up to 132 months, beyond 78
months offollow-up only one case progressed to malignancy.
Thus, further analysis regarding progression by various fac-
tors was limited to 78 months of follow-up. The progression
rate among all dysplasias at 78 months was observed to be
13.0%. Progression among initially moderate dysplasia was
24.3% as compared to 4.9% among the mild dysplasia
category. The rate of progression among severe dysplasia was
found to be 42.0% at the end of 36 months of follow-up.
Table I Follow-up rate in dysplasia cases at different follow-up
periods
Ordinal month of Expected no. Observed no. Rate offollow-up
follow-up ofwomen ofwomen (%)
12 862 810 94.0
24 699 546 78.0
36 478 373 78.0
48 367 272 74.1
60 251 201 80.0
72 167 142 85.0
84 138 108 78.3
96 121 97 80.1
108 76 63 82.9
120 32 25 78.1
132 10 10 100.0734 N.S. MURTHY et al.
Table II Cumulative rates of progression to malignancy among
initially mild, moderate, severe and all dysplasias
Initial grade ofdysplasia
Mild Moderate Severe All dysplasia
Follow-up No. of Cum. No. of Cum. No. of Cum. No. of Cwn.
period women rate women rate women rate women rate
(months) at risk (%) at risk (%) at risk (%) at risk (%)
6 648 0.3 253 3.4 51 12.0 952 1.7
12 555 1.0 217 7.2 38 20.7 810 3.8
18 458 1.2 177 10.8 32 25.1 667 5.2
24 368 1.7 151 11.4 27 27.5 546 5.8
30 296 2.3 134 13.6 19 37.2 443 7.2
36 249 2.7 116 16.0 8 42.0 373 8.4
42 217 2.7 103 17.5 6 42.0 326 9.0
48 185 2.7 81 20.1 6 42.0 272 9.8
54 169 2.7 63 22.4 5 42.0 237 10.9
60 145 4.0 52 22.4 2 42.0 201 11.3
66 124 4.0 40 22.4 1 42.0 165 11.8
72 106 4.0 35 24.4 1 42.0 142 12.4
78a 84 4.9 29 24.4 1 42.0 114 13.0
aBeyond 78monthsonlyonewomenprogressedtomalignancyduring
follow-up of 108 months.
Women with severe dysplasia followed up beyond 42 months
were few. The differences in cumulative progression rates
between different grades of dysplasia were found to be statis-
tically significant (P<0.05).
Transitional interval to malignancy
The mean transition intervals for progression to carcinoma in
situ for the initially mild (n = 15), moderate (n = 42) and
severe (n = 18) dysplasia were observed to be 26.6, 21.7 and
12.1 months, respectively, from registration. The mean inter-
val for all dysplasia cases combined together was 20.3
months. The mean transition interval did not show variation
with regard to different risk factors (data not shown).
Role ofdifferentfactors in progression to malignancy
Relative risks for progression to malignancy were calculated
according to different factors such as religion, literacy status
of women, age at consummation of marriage (ACM), ever
usage of family planning methods, total pregnancies, history
of fetal loss, detection of cervical erosion at initial examina-
tion and detection of antibodies to herpes simplex virus I and
II.
The data structure of the various risk factors included for
analysis of the proportional hazards model, and the relative
risk of univariate regressions, are given in Table III. The
analysis revealed that the relative risks for age at consumma-
tion of marriage, literacy status of women and total number
of pregnancies were found to be statistically significant.
Women with consummation of marriage before 18 years had
a 2.8-fold (P<0.05) higher risk of development of malig-
nancy as compared to women with ACM over 18 years.
Similarly, increasing number of pregnancies carried a higher
risk and the associated relative risk was 1.1 (P<0.05). The
illiterate women had a 1.74 times higher risk (P<0.06) for
development of malignancy than literate women.
The relative risks relating to other risk factors, i.e. religion,
age of women at detection of malignancy, usage of family
planning methods, fetal loss, cervical erosion, antibodies to
HSV versus no antibodies to HSV and HSV I versus HSV-II,
did not attain statistical significance. Thus the risk of pro-
gression to malignancy was not dependent on the above
factors.
The stepwise analysis was performed according to the
importance of the risk factors as observed through the
univariate model. Each variable was added to the model in
turn and their differences in the deviances were taken to test
the statistical significance. The results revealed the ACM as a
single independent contributing risk factor related to progres-
sion of dysplasia to malignancy (Table IV). The other two
factors, literacy status and total pregnancies, failed to attain
Table III Univariate Cox regression analysis for progression to
malignancy
No. ofwomen No. ofcases
years of progressed to Relative Globalx2
Variable follow-up malignancy risk (P value)
Age ofwomen
<35 years 1686 38 1.21 0.49
>35 years 1310 37 (0.48)
Literacy ofwife
Illiterate 1687 51 1.74 3.50
Literate 1309 24 (0.06)
Religion
Hindu 2566 66 1.08 0.03
Muslim 259 5 (0.87)
Age at consummation
ofmarriage (ACM)
< 18 years 2262 63 2.82 5.32
> 18 years 734 12 (0.02)
Users of FP
methods
Ever used 580 12 0.75 1.42
Never used 2416 63 (0.35)
Total pregnancies
2996 75 1.11 4.07
(0.04)
Fetal loss
No 2128 49 1.10 0.10
Yes 868 26 (0.75)
Cervical erosion
Yes 1357 38 1.21 0.47
No 1639 37 (0.49)
HSV
I + II 2546 65 1.55 2.60
No ab. 450 10 (0.11)
HSV II 1225 41 1.33 0.69
I + No ab. 1771 34 (0.41)
HSVa
II 1225 41 1.38 2.44
I 1325 24 (0.12)
aSample sizewasdifferentaswomen negative to HSV antibodieswere
excluded. Relative risk = exp (reg. coeff.).
Table IV Stepwise Cox regression analysis
Variables entered Log Improved Global X2
in the model likelihood x2 (P value) d.f.
ACM -313.39 5.32 1
(0.02)
ACM, total preg. -312.25 2.28 7.85 2
(0.02)
ACM, total preg., -311.74 1.02 8.81 3
literacy (0.03)
significance when controlled for ACM. The stratified analysis
of the Cox regression model according to initial grades of
dysplasia also revealed the same findings. Similarly, the
analysis carried out to the end of 108 months offollow-up by
adding one case which progressed beyond 78 months of
follow-up made no material difference to the results.
Of the total dysplasia cases 20.8% used family planning
methods. IUD was being used by 3.3% while hormones were
used by only 0.5% of women. The remainder of the women
used termination of pregnancy or other methods.
Detection ofHPV DNA sequences by in situ hybridisation
The results of investigations for HPV revealed that of 63
progressive cases, 43 (68.3%) were found to be positive for
HPV 16 and 18 DNA sequences, while out of 44 non-
progressive cases, 12 (27.3%) were positive for HPV 16 and
18 DNA sequences. The difference was statistically significant
(P<0.001) with a relative risk of 5.9 (95% CI = 2.5, 14.1).
Discussion
The combined use of cytology and colposcopic monitoring
provides a good opportunity to study factors whichPRECANCEROUS LESIONS OF UTERINE CERVIX 735
influence/determine the ultimate behaviour of dysplasias. The
study was designed to follow up registered cases of dysplasia
without any intervention. However, 103 (9.3%) cases were
dropped during follow-up as they underwent hysterectomies
for reasons other than progression to cancer. The hysterect-
omy rate was 3.4 per 100 women years. The hysterectomy
rate for severe dysplasia was 8.69 per 100 women year, and
for moderate and mild dysplasia the rates were 4.47 and 2.73
for 100 women years respectively. Hysterectomy rates for the
controls were 1.1 per 100 women years (i.e. 30 cases (2.8%)),
which were significantly lower than the hysterectomy rates
for the matched dysplasia. The reason for differential
hysterectomy rates remains unknown. However, this is not
likely to affect the cumulative risk of progression as it has
been shown that women undergoing hysterectomies for non-
malignant conditions are probably at a lower risk ofdevelop-
ing cancer of cervix than the general population (Miller,
1986).
As expected, the important determinant of risk of progres-
sion to malignancy was found to be the initial grade/severity
of the preneoplastic changes. The rate of progression of
severe dysplasia (42.0%) was considerably higher than pro-
gression of initially moderate dysplasia (24.3%) and initially
mild dysplasia (4.9%) to cancer. The time lead bias alone
may not explain this difference as sufficient time (132
months) was given to observe the behaviour or progression
pattern of initially mild and moderate dysplasias. This
indicates that mild and moderate dysplasia possibly con-
stitutes a more heterogeneous category of cellular abnor-
malities with a variable potential of progression compared to
sever dysplasia.
Progression to malignancy was found to be influenced by
age at consummation of marriage (ACM). Women with con-
summation of marriage under 18 years of age had a 2.8-fold
higher progression than those with ACM over 18 years. This
may be possibly due to sexual insult to the younger cervix.
We feel that earlier ACM increases the susceptibility of the
cervix to the further action of carcinogens (Brinton & Frau-
ment, 1986; Luthra et al., 1987). That young tissue is more
susceptible for the development of cancer has been shown for
other cancers, notably hepatoma due to hepatitis B virus
infection during the perinatal period. For oral cancer it has
also been shown that initiation of tobacco chewing during
adolescence increases the risk of oral cancer by 10-fold
(Wahi, 1968).
It has been observed in Indian situations that Muslims
have a lower incidence of cervical cancer than Hindus (Wahi
et al., 1972; Jussawala et al., 1971). In this study, however,
Muslim women with a significantly earlier age of consumma-
tion of marriage did not show significantly higher progres-
sion rates than Hindus. On the contrary, their progression
rates were much lower, although not statistically significantly
(P>0.05). This could imply the presence of some protective
factors operating in the Muslim women, such as better nutri-
tion and genital hygiene. These factors, however, need to be
evaluated in the Indian situation as malnutrition and poor
genital hygiene are widely prevalent among Hindus,
especially in the lower socio-economic class. A recent WHO
report (WHO, 1986) considers genital hygiene to be an
important factor in the Indian situation, especially when
circumcision provides better penile hygiene.
Usage of family planning methods did not have any
significant effect in modifying the progression rates to malig-
nancy from dysplasia. It could be due to the fact that the
large majority of subjects resorted to terminal methods of
family planning, in both dysplasia and control groups.
In the present study women who revealed cervical erosion
at the initial examination did not show a higher progression
rate of malignancy than those without erosions. It has been
shown earlier that diathermy coagulation of erosions leads to
reduced risk of progression compared to no treatment
(Vonka et al., 1984a). In the present study, none of the
erosions were treated. It could be that diathermy coagulation
might have lowered the progression rates by destroying the
transformation zone containing initiated cells. Thus erosion
itself may not be an important risk factor for progression.
Three different analysis were made for studying HSV: (i)
HSV I + II vs no antibody; (ii) HSV II vs HSV I + no
antibody; (iii) HSV-II vs HSV-I. No significant increase in
the progression rates was observed for dysplasia with any of
the above combinations. Two prospective studies (Vonka et
al., 1984b; Adam et al., 1985) employing a similar technology
also failed to reveal any significant role of HSV in the
process of cervical carcinogenesis.
At present the most seriously considered micro-organism is
selective types of genital human papilloma virus (HPV). It
has been reported that the risk of progression was con-
siderably elevated in subjects with HPV infection (Howley,
1986).
Our investigations on HPV were carried out on the ret-
rospective material only, employing a case-control design.
Investigations for HPV could not be undertaken on the
entire cohort as the significance of HPV as a possible
aetiological agent was only realised globally during the later
part of our study. For non-progressive cases, the investiga-
tions for HPV were carried out on the biopsies collected at
the termination of the cohort. In progressive cases, the
biopsy specimen obtained at the diagnosis of CIS was used
for detection of HPV DNA sequences. With all these limita-
tions, we obtained a very high odds ratio of 5.9 associated
with progressive cases.
The study revealed that the 'sojourn time' for various
grades of dysplasia did not differ according to various risk
factors. This is inconsistent with the findings of others
(Hakama, 1986).
In conclusion, the only risk modifiers identifiable in our
study were initial grade of dysplasia, ACM (< 18 years) and
the presence of HPV 16/18.
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